These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 20112269)
1. Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1-1 cm after secondary cytoreduction. Tian WJ; Jiang R; Cheng X; Tang J; Xing Y; Zang RY J Surg Oncol; 2010 Mar; 101(3):244-50. PubMed ID: 20112269 [TBL] [Abstract][Full Text] [Related]
2. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412 [TBL] [Abstract][Full Text] [Related]
3. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030 [TBL] [Abstract][Full Text] [Related]
4. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441 [TBL] [Abstract][Full Text] [Related]
5. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data. Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965 [TBL] [Abstract][Full Text] [Related]
6. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
7. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302 [TBL] [Abstract][Full Text] [Related]
8. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer]. Li YF; Li MD; Liu FY; Liu JH; Li JD Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651 [TBL] [Abstract][Full Text] [Related]
9. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956 [TBL] [Abstract][Full Text] [Related]
10. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603 [TBL] [Abstract][Full Text] [Related]
11. Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer. Park JY; Eom JM; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH J Surg Oncol; 2010 Apr; 101(5):418-24. PubMed ID: 20082350 [TBL] [Abstract][Full Text] [Related]
12. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
13. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281 [TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420 [TBL] [Abstract][Full Text] [Related]
15. Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series. Shih KK; Chi DS; Barakat RR; Leitao MM Gynecol Oncol; 2010 May; 117(2):330-5. PubMed ID: 20189234 [TBL] [Abstract][Full Text] [Related]
16. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Benedetti Panici P; De Vivo A; Bellati F; Manci N; Perniola G; Basile S; Muzii L; Angioli R Ann Surg Oncol; 2007 Mar; 14(3):1136-42. PubMed ID: 17195909 [TBL] [Abstract][Full Text] [Related]
17. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients. Zang RY; Yang WT; Shi DR; Xing Y; Cai SM J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350 [TBL] [Abstract][Full Text] [Related]
18. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Bristow RE; Montz FJ Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412 [TBL] [Abstract][Full Text] [Related]
19. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy. Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820 [TBL] [Abstract][Full Text] [Related]